Global Radiopharmaceuticals Market Report 2024

Radiopharmaceuticals Global Market Report 2023 – By Type (Diagnostic, Therapeutic, Other Types), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Radiopharmaceuticals Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Radiopharmaceuticals refer to a medication used to treat or diagnose diseases, including cancer, that contains a radioactive material. Likewise known as radioactive medication. These are the procedures used to identify certain illnesses or detect medical issues. The patient may receive them in a number of different ways. They could be injected, injected orally, or injected into the eye or bladder, for instance.

The main types of radiopharmaceuticals are diagnostic, therapeutic, and others. The delivery of radioactive atoms to tumor-associated targets is referred to as radiopharmaceutical therapeutic. The various applications include oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology, and others that are used by hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, and others.

The global radiopharmaceuticals market is segmented -

1) By Type: Diagnostic, Therapeutic, Other Types

2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, and Other End Users

The global radiopharmaceuticals market size will grow from $5.9 billion in 2022 to $6.17 billion in 2023 at a compound annual growth rate (CAGR) of 4.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global radiopharmaceuticals is expected to grow from $8.25 billion in 2027 at a CAGR of 7.5%.

The increasing prevalence of cancer and cardiovascular diseases is projected to drive the demand for the radiopharmaceuticals market. Radiopharmaceuticals are emerging as a safe and effective therapeutic option over conventional medicines. Radiopharmaceuticals provide an upper hand to radiologists to treat cancer and cardiovascular diseases due to their benefits such as targeted therapy. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. According to the International Agency for Research on Cancer (IARC), by 2040, the global burden is projected to increase to 27.5 million active cancer incidents and 16.3 million cancer deaths primarily due to population growth and aging. About 70% of deaths from cancer occur in low- and middle-income countries. Thus, the rising cases of cancer and cardiovascular diseases are expected to surge the demand for radiopharmaceuticals for the treatment of these diseases.

Major players in the radiopharmaceuticals market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Nordion Inc. (A subsidiary of Sterigenics International), Mallinckrodt PLC., Curium, Eckert & Ziegler, Eli Lilly, Eckert & Ziegler, IBA Group, Merck & Co. Inc., Philips Healthcare, Fujifilm Holding Corporation, Areva Pharma, Navidea Biopharmaceuticals Inc., Actinium Pharmaceuticals Inc., Global Medical Solutions LTD., and Shine Medical Technologies.

The high cost of radiopharmaceuticals is anticipated to limit the growth of the market. High costs and short half-life of radiopharmaceuticals are reducing their implementation in hospitals and clinics. The development cost of radiopharmaceuticals is very high compared to that of therapeutic drugs and also undergoes a very lengthy and expensive regulatory process. For instance, the cost of diagnostic radiopharmaceuticals development is $100 to $200 million for 8-10 years in comparison with the cost of pharmaceuticals, which ranges between $600 million to $1.2 billion for 10-12 years. Therefore, the high cost of radiopharmaceuticals is likely to act as a major restraint on market growth.

Research collaborations and partnerships are gaining significant popularity in the radiopharmaceuticals market over recent years. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business. For instance, in March 2020, Debiopharm, a Switzerland-based biopharmaceutical company, signed a research agreement with 3B Pharmaceuticals (3BP), a Germany-based biotechnology firm, to develop the Debio 0228 radioligand program, targeting CAIX (Carbonic Anhydrase 9) enzyme to fight the progression of cancer.

Many companies are adopting various strategic initiatives, such as opening a new manufacturing facility and expanding plant capacity, which is gaining significant popularity in the radiopharmaceuticals market. For instance, ITM Isotopen Technologien Munchen AG (ITM) announced the launch of its new manufacturing facility in the Munich area to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177 containing radiopharmaceuticals. Lutetium-177 is popular under the brand EndolucinBeta and is an innovative isotope used in cancer therapy. This is the company’s step towards meeting the high demand for quality medical isotopes for precision oncology worldwide.

In June 2021, Curium, a France-based nuclear medicine solution provider, acquired IASON for an undisclosed amount. Through this acquisition, Curium is expected to increase its footprint in Europe for its extensive selection of life-saving diagnostic techniques. This acquisition expands Curium's geographic reach, allowing it to reach clients and patients throughout Austria and Central Europe with its wide range of medications and future pipeline of novel agents. IASON is an Austria-based expert in radiopharmaceutical development, manufacturing, and distribution for use in positron-emission tomography (PET).

North America was the largest region in the global radiopharmaceuticals market in 2022. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the global radiopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The radiopharmaceuticals market consists of sales of technetium disofenin, technetium lidofenin, and technetium mebrofenin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The radiopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals market statistics, including radiopharmaceuticals industry global market size, regional shares, competitors with a radiopharmaceuticals market share, detailed radiopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceuticals industry. This radiopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Radiopharmaceuticals Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Type

    6.3. Segmentation By Application

    6.4. Segmentation By End User

    7. Radiopharmaceuticals Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Type

    7.2.1. Diagnostic

    7.2.2. Therapeutic

    7.3. Segmentation By Application

    7.3.1. Oncology

    7.3.2. Cardiology

    7.3.3. Musculoskeletal

    7.3.4. Neuroendocrinology

    7.3.5. Respiratory

    7.3.6. Nephrology

    7.3.7. Others

    7.4. Segmentation By End-User

    7.4.1. Hospitals And Ambulatory Surgical Centers

    7.4.2. Diagnostic Centers

    7.4.3. Cancer Research Institutes

    8. Radiopharmaceuticals Market Trends And Strategies

    8.1. Research Collaborations And Partnerships

    8.2. Plant Capacity Expansion

    8.3. 3D Printing Technology

    8.4. Technological Developments

    8.5. Investments In Innovation

    8.6. In Silico Modeling

    8.7. Investment In Artificial Intelligence

    8.8. Dominance of Cardiology

    8.9. Radiopharmaceutical Cancer Therapy

    9. Impact Of COVID-19 On The Radiopharmaceuticals Market

    9.1. Introduction

    9.2. Impact On Laboratories And Procedures

    9.3. Impact On Inpatient And Outpatient Radiopharmaceutical Operations

    9.4. Supply and Demand Disruptions

    9.5. Conclusion

    10. Global Radiopharmaceuticals Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3.Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global Radiopharmaceuticals Market Segmentation

    11.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12. Radiopharmaceuticals Market, Regional And Country Analysis

    12.1. Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.1.1. North America

    12.1.2. Asia Pacific

    12.1.3. Africa

    12.2. Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2.1. USA

    12.2.2. China

    13. Asia-Pacific Radiopharmaceuticals Market

    13.1. Asia-Pacific Radiopharmaceuticals Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. Background Information

    13.1.4. Government Initiatives

    13.1.5. Regulations

    13.1.6. Regulatory Bodies

    13.1.7. Major Associations

    13.1.8. Taxes Levied

    13.1.9. Corporate Tax Structure

    13.1.10. Investments

    13.1.11. Major Companies

    13.2. Asia-Pacific Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.4.Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.5. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.6.Asia-Pacific Radiopharmaceuticals Market: Country Analysis

    13.7. China Radiopharmaceuticals Market

    13.8.China Radiopharmaceuticals Market Overview

    13.8.1. Country Information

    13.8.2. Market Information

    13.8.3. Background Information

    13.8.4. Government Initiatives

    13.8.5. Regulations

    13.8.6. Regulatory Bodies

    13.8.7. Major Associations

    13.8.8. Taxes Levied

    13.8.9. Corporate Tax Structure

    13.8.10. Investments

    13.8.11. Major Companies

    13.9.China Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.10. China Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.11. China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.12. China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.13. India Radiopharmaceuticals Market

    13.14. India Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.15. India Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.16. India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.17. India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.18. Japan Radiopharmaceuticals Market

    13.19. Japan Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.20. Japan Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.21. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.22. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.23. Australia Radiopharmaceuticals Market

    13.24. Australia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.25. Australia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.26. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.27. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.28. Indonesia Radiopharmaceuticals Market

    13.29. Indonesia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.30. Indonesia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.31. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.32. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.33. South Korea Radiopharmaceuticals Market

    13.34. South Korea Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.35. South Korea Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.36. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.37. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14. Western Europe Radiopharmaceuticals Market

    14.1.Western Europe Radiopharmaceuticals Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Background Information

    14.1.4. Government Initiatives

    14.1.5. Regulations

    14.1.6. Regulatory Bodies

    14.1.7. Major Associations

    14.1.8. Taxes Levied

    14.1.9. Corporate Tax Structure

    14.1.10. Investments

    14.1.11. Major Companies

    14.2. Western Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3.Western Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.4. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.5. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.6. Western Europe Radiopharmaceuticals Market: Country Analysis

    14.7. UK Radiopharmaceuticals Market

    14.8. UK Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.9. UK Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.10. UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.11. UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.12. Germany Radiopharmaceuticals Market

    14.13. Germany Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.14. Germany Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.15. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.16. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.17. France Radiopharmaceuticals Market

    14.18. France Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.19. France Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.20. France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.21. France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15. Eastern Europe Radiopharmaceuticals Market

    15.1. Eastern Europe Radiopharmaceuticals Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Background Information

    15.1.4. Government Initiatives

    15.1.5. Regulations

    15.1.6. Regulatory Bodies

    15.1.7. Major Associations

    15.1.8. Taxes Levied

    15.1.9. Corporate Tax Structure

    15.1.10. Investments

    15.1.11. Major Companies

    15.2. Eastern Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.3. Eastern Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.5. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.6. Eastern Europe Radiopharmaceuticals Market: Country Analysis

    15.7. Russia Radiopharmaceuticals Market

    15.8. Russia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.9. Russia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.10. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.11. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16. North America Radiopharmaceuticals Market

    16.1.North America Radiopharmaceuticals Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Background Information

    16.1.4. Government Initiatives

    16.1.5. Regulations

    16.1.6. Regulatory Bodies

    16.1.7. Major Associations

    16.1.8. Taxes Levied

    16.1.9. Corporate Tax Structure

    16.1.10. Investments

    16.1.11. Major Companies

    16.2. North America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3.North America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.4. North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.5. North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.6. North America Radiopharmaceuticals Market: Country Analysis

    16.7. USA Radiopharmaceuticals Market

    16.8. USA Radiopharmaceuticals Market Overview

    16.8.1. Country Information

    16.8.2. Market Information

    16.8.3. Background Information

    16.8.4. Government Initiatives

    16.8.5. Regulations

    16.8.6. Regulatory Bodies

    16.8.7. Major Associations

    16.8.8. Taxes Levied

    16.8.9. Corporate Tax Structure

    16.8.10.Investments

    16.8.11. Major Companies

    16.9. USA Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.10. USA Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.11. USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.12. USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17. South America Radiopharmaceuticals Market

    17.1. South America Radiopharmaceuticals Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Background Information

    17.1.4. Government Initiatives

    17.1.5. Regulations

    17.1.6. Regulatory Bodies

    17.1.7. Associations

    17.1.8. Taxes Levied

    17.1.9. Corporate Tax Structure

    17.1.10. Investments

    17.1.11. Major Companies

    17.2. South America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.3. South America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.4. South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.5. South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.6. South America Radiopharmaceuticals Market: Country Analysis

    17.7. Brazil Radiopharmaceuticals Market

    17.8. Brazil Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.9. Brazil Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.10. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.11. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18. Middle East Radiopharmaceuticals Market

    18.1. Middle East Radiopharmaceuticals Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Background Information

    18.1.4. Government Initiatives

    18.1.5. Regulations

    18.1.6. Regulatory Bodies

    18.1.7. Major Associations

    18.1.8. Taxes Levied

    18.1.9. Investments

    18.1.10. Major Companies

    18.2. Middle East Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    18.3.Middle East Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    18.4. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18.5. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19. Africa Radiopharmaceuticals Market

    19.1.Africa Radiopharmaceuticals Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Background Information

    19.1.4. Government Initiatives

    19.1.5. Regulations

    19.1.6. Regulatory Bodies

    19.1.7. Major Associations

    19.1.8. Taxes levied

    19.1.9. Investments

    19.1.10. Major Companies

    19.2. Africa Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.3.Africa Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.4. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.5. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20. Global Radiopharmaceuticals Market Competitive Landscape

    20.1. Company Profiles

    20.2. Cardinal Health

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Curium Pharma

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Siemens Healthineers AG

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Novartis AG

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. General Electric Company (GE)

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Radiopharmaceuticals Market Pipeline Analysis

    22. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

    22.1. Bayer Acquired Noria Therapeutics And PSMA Therapeutics

    22.2. Curium Acquired MAP Medical Technologies Oy

    22.3. ISOLOGIC Acquired Diagnostic FDG Distribution From CPDC

    22.4. TTG Imaging Solutions Acquired NISotopes

    22.5. Curium Acquired MAP Medical Technologies Oy

    22.6. Progenics Acquired Orphan Radiopharmaceuticals

    22.7. Novartis Acquired Endocyte

    22.8. Jubilant Pharma Acquired Triad Isotopes

    22.9. Pharmalogic Acquired Radiopharmacy of Paducah

    22.10. IBA Molecular Acquired Mallinckrodt Nuclear Imaging

    23. Global Radiopharmaceuticals Market Opportunities And Strategies

    23.1. Global Radiopharmaceuticals Market In 2025 – Countries Offering Most New Opportunities

    23.2. Global Radiopharmaceuticals Market In 2025 – Segments Offering Most New Opportunities

    23.3.Global Radiopharmaceuticals Market In 2025 – Growth Strategies

    23.3.1. Market Trend Based Strategies

    23.3.2. Competitor Strategies

    24. Radiopharmaceuticals Market, Conclusions And Recommendations

    24.1. Conclusions

    24.2. Recommendations

    24.2.1. Product

    24.2.2. Place

    24.2.3. Price

    24.2.4. Promotion

    24.2.5. People

    25. Appendix

    25.1. Market Data Sources

    25.2. Research Methodology

    25.3. Currencies

    25.4. Research Inquiries

    25.5. The Business Research Company

    25.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13: Asia-Pacific Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 14: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 15: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 16: Asia-Pacific Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 17: Asia-Pacific Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 18: Asia-Pacific Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 19: Asia-Pacific Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 20: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 21: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 22: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 23: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 24: China Healthcare Expenditure, 2015-2019, $ Billion
  • Table 25: China GDP Per Capita, 2015-2020, $
  • Table 26: China, Population By Age Group, 2015-2025, Thousands
  • Table 27: China Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 28: China Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 29: China Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 30: China Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 31: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 32: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 33: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 34: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 35: India Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 36: India Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 37: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 38: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 39: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 40: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 41: Japan Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 42: Japan Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 43: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 44: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 45: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 46: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 47: Australia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 48: Australia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 49: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 50: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 51: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 52: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 53: Indonesia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 54: Indonesia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 55: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 56: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 57: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 58: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 59: South Korea Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 60: South Korea Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 61: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 62: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 63: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 64: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 65: Western Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 66: Western Europe GDP Per Capita, 2015-2020, $
  • Table 67: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 68: Western Europe Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 69: Western Europe Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 70: Western Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 71: Western Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 72: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 73: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 74: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76: UK Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 77: UK Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 78: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 79: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 80: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 81: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 82: Germany Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 83: Germany Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 84: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 85: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 86: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 87: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 88: France Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 89: France Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 90: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 91: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 92: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 93: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 94: Eastern Europe Expenditure, By Country, 2015-2019, $ Billion
  • Table 95: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 96: Eastern Europe Population By Age Group, By Country, 2015-2025, Thousands
  • Table 97: Eastern Europe Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 98: Eastern Europe Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 99: Eastern Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 100: Eastern Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 101: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 102: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 103: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 104: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 105: Russia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 106: Russia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 107: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 108: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 109: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 110: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 111: North America Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 112: North America GDP Per Capita, 2015-2020, $
  • Table 113: North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 114: North America Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 115: North America Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 116: North America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 117: North America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 118: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 119: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 120: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 121: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 122: USA Healthcare Expenditure, 2015-2019, $ Billion
  • Table 123: USA GDP Per Capita, 2015-2020, $
  • Table 124: USA, Population By Age Group, 2015-2025, Thousands
  • Table 125: USA Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 126: USA Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 127: USA Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 128: USA Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 129: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 130: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 131: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133: South America Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 134: South America GDP Per Capita, 2015-2020, $
  • Table 135: South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 136: South America Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 137: South America Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 138: South America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 139: South America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 140: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 141: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 142: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 143: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 144: Brazil Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 145: Brazil Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 146: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 147: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 148: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 149: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 150: Middle East Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 151: Middle East GDP Per Capita, 2015-2020, $
  • Table 152: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 153: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 154: Middle East Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 155: Middle East Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 156: Middle East Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 157: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 158: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 159: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 160: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 161: Africa Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 162: Africa GDP Per Capita, 2015-2020, $
  • Table 163: Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 164: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 165: Africa Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
  • Table 166: Africa Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 167: Africa Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 168: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 169: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 170: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 171: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 172: Global Radiopharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 173: Cardinal Health – Financial Overview, 2016 - 2020, $ Billion
  • Table 174: Siemens Healthineers AG – Financial Overview, 2016 - 2020, $ Billion
  • Table 175: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
  • Table 176: General Electric Company (GE) – Financial Overview, 2016 - 2020, $ Billion
  • Table 177: Global Radiopharmaceuticals Market, Pipeline Analysis
  • Table 178: Global Radiopharmaceuticals Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 179: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
  • Table 180: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
  • Table 181: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
  • Table 182: Radiopharmaceuticals - Market Data Sources

List Of Figures

    Figure 1: Global Radiopharmaceuticals Market Segmentation By Type
  • Figure 2: Global Radiopharmaceuticals Market Segmentation By Application
  • Figure 3: Global Radiopharmaceuticals Market Segmentation By End User
  • Figure 4: Global Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 5: Global Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 6: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 11: Asia-Pacific Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 12: Asia-Pacific Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 13: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: China Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 16: China Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 17: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 18: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 19: India Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 20: India Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 21: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 22: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 23: Japan Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 24: Japan Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 27: Australia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 28: Australia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 29: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 31: Indonesia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 32: Indonesia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 35: South Korea Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 36: South Korea Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 37: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 38: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: Western Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 40: Western Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 41: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 42: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43: UK Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 44: UK Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 45: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 47: Germany Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 48: Germany Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 49: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 50: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: France Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 52: France Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55: Eastern Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 56: Eastern Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 59: Russia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 60: Russia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 61: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 62: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 63: North America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 64: North America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 66: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 67: USA Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 68: USA Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 70: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 71: South America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 72: South America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 73: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75: Brazil Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 76: Brazil Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 78: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 79: Middle East Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 80: Middle East Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 83: Africa Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 84: Africa Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 86: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 87: Global Radiopharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 88: Cardinal Health – Financial Overview, 2016 – 2020, $ Billion
  • Figure 89: Siemens Healthineers AG – Financial Overview, 2016 – 2020, $ Billion
  • Figure 90: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
  • Figure 91: General Electric Company (GE)  – Financial Overview, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report